Rescue of Nephrons With ALE.F02 (RENAL-F02)

NCT06047171 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Glomerulonephritis Rapidly Progressive

Interventions

BIOLOGICAL: ALE.F02
DRUG: Rituximab
DRUG: GlucoCorticoid
DRUG: Cyclophosphamid
DRUG: Placebo
DRUG: Immunosuppressive Agents

Sponsor

Alentis Therapeutics AG